Photo Rounds

Leg rash

A 67-year-old man presented to Dermatology with a 3-week history of bilateral thin erosions on his medial thighs. He said that he was vacationing in Florida when he first noticed that his thighs were mildly itchy. He applied a topical therapy that he had from a previous bout of eczema but that only made things worse. The patient had a history of Grover disease, cutaneous squamous cell carcinomas, and multiple actinic keratoses.

What’s your diagnosis?


 

References

Leg rash

Punch biopsies for standard pathology and direct immunofluorescence were performed and ruled out vesiculobullous disease. Further conversation with the patient revealed that this was a phototoxic drug eruption that resulted from a medication mix-up. The patient had intended to treat an eczema flare with a topical steroid but had inadvertently applied 5-fluorouracil (5-FU), which he had left over from a previous bout of actinic keratosis. While selective to precancerous cells with rapid DNA replication, 5-FU can trigger a significant photodermatitis when applied to heavily sun-exposed skin.

Phototoxic skin reactions can be an adverse result of multiple systemic and topical therapies. Common systemic examples include amiodarone, chlorpromazine, doxycycline, hydrochlorothiazide, isotretinoin, nalidixic acid, naproxen, piroxicam, tetracycline, thioridazine, vemurafenib, and voriconazole.1 Topical examples include retinoids, levulinic acid, and 5-FU. Treatment requires that the patient stop the offending medication and use photoprotection. The patient followed this protocol and his erosions resolved over the course of a few weeks.

This case demonstrates that topical therapies, like systemic medications, can have chemical names that are confusing to patients. Further complicating matters can be the practice of folding metal tubes of cream over their life of use, thus obscuring the label.

Photos and text for Photo Rounds Friday courtesy of Jonathan Karnes, MD (copyright retained). Dr. Karnes is the medical director of MDFMR Dermatology Services, Augusta, ME.

Recommended Reading

Why it’s important for dermatologists to learn about JAK inhibitors
MDedge Family Medicine
Consider essential oil allergy in patient with dermatitis
MDedge Family Medicine
Abrocitinib evaluated in patients with and without prior dupilumab treatment
MDedge Family Medicine
Second opinions on melanocytic lesions swayed when first opinion is known
MDedge Family Medicine
Asian patients with psoriasis have shortest visits, study shows
MDedge Family Medicine
Body contouring tops list of cosmetic procedures with adverse event reports
MDedge Family Medicine
Autoimmune disease patients’ waxing, waning response to COVID vaccination studied in-depth
MDedge Family Medicine
Superolateral knee injection with a patellar tilt for osteoarthritis pain
MDedge Family Medicine
VTE risk not elevated in AD patients on JAK inhibitors: Study
MDedge Family Medicine
Chlorophyll water can trigger pseudoporphyria, expert warns
MDedge Family Medicine